| . | CRT-D . | CRT-P . | All . |
|---|---|---|---|
| N (50 084) | 25 273 | 24 811 | 50 084 |
| Sex (male) | 20 423 (80.81) | 17 088 (68.87) | 37 511 (74.90) |
| Age (years) | 68.1 ± 11.1 | 74.3 ± 11.3 | 71.2 ± 11.6 |
| <60 | 4950 (19.59) | 2336 (9.42) | 7286 (14.55) |
| 60–69 | 7184 (28.43) | 4202 (16.94) | 11 386 (22.73) |
| 70–79 | 10 079 (39.88) | 9150 (36.88) | 19 229 (38.39) |
| ≥80 | 3060 (12.11) | 9123 (36.77) | 12 183 (24.33) |
| Charlson Comorbidity Index | |||
| 0 | 5924 (23.44) | 7022 (28.30) | 12 946 (25.85) |
| 1 | 8270 (32.72) | 7549 (30.43) | 15 819 (31.58) |
| 2 | 5765 (22.81) | 4824 (19.44) | 10 589 (21.14) |
| ≥3 | 5314 (21.03) | 5416 (21.83) | 10 730 (21.42) |
| Ischaemic aetiology, n (%) | 16 971 (67.15) | 13 901 (56.03) | 30 872 (61.64) |
| History, n (%) | |||
| Hypertension | 14 565 (57.63) | 14 599 (58.84) | 29 164 (58.23) |
| Diabetes | 6905 (27.32) | 6056 (24.41) | 12 961 (25.88) |
| Chronic kidney disease | 3127 (12.37) | 3924 (15.82) | 7051 (14.08) |
| Myocardial infarction | 4092 (16.19) | 2466 (9.94) | 6558 (13.09) |
| CABG | 1354 (5.36) | 834 (3.36) | 2188 (4.37) |
| . | CRT-D . | CRT-P . | All . |
|---|---|---|---|
| N (50 084) | 25 273 | 24 811 | 50 084 |
| Sex (male) | 20 423 (80.81) | 17 088 (68.87) | 37 511 (74.90) |
| Age (years) | 68.1 ± 11.1 | 74.3 ± 11.3 | 71.2 ± 11.6 |
| <60 | 4950 (19.59) | 2336 (9.42) | 7286 (14.55) |
| 60–69 | 7184 (28.43) | 4202 (16.94) | 11 386 (22.73) |
| 70–79 | 10 079 (39.88) | 9150 (36.88) | 19 229 (38.39) |
| ≥80 | 3060 (12.11) | 9123 (36.77) | 12 183 (24.33) |
| Charlson Comorbidity Index | |||
| 0 | 5924 (23.44) | 7022 (28.30) | 12 946 (25.85) |
| 1 | 8270 (32.72) | 7549 (30.43) | 15 819 (31.58) |
| 2 | 5765 (22.81) | 4824 (19.44) | 10 589 (21.14) |
| ≥3 | 5314 (21.03) | 5416 (21.83) | 10 730 (21.42) |
| Ischaemic aetiology, n (%) | 16 971 (67.15) | 13 901 (56.03) | 30 872 (61.64) |
| History, n (%) | |||
| Hypertension | 14 565 (57.63) | 14 599 (58.84) | 29 164 (58.23) |
| Diabetes | 6905 (27.32) | 6056 (24.41) | 12 961 (25.88) |
| Chronic kidney disease | 3127 (12.37) | 3924 (15.82) | 7051 (14.08) |
| Myocardial infarction | 4092 (16.19) | 2466 (9.94) | 6558 (13.09) |
| CABG | 1354 (5.36) | 834 (3.36) | 2188 (4.37) |
All comparisons between CRT-D and CRT-P were significant (P < 0.001).
CABG, coronary artery bypass grafting; CRT, cardiac resynchronization therapy.
| . | CRT-D . | CRT-P . | All . |
|---|---|---|---|
| N (50 084) | 25 273 | 24 811 | 50 084 |
| Sex (male) | 20 423 (80.81) | 17 088 (68.87) | 37 511 (74.90) |
| Age (years) | 68.1 ± 11.1 | 74.3 ± 11.3 | 71.2 ± 11.6 |
| <60 | 4950 (19.59) | 2336 (9.42) | 7286 (14.55) |
| 60–69 | 7184 (28.43) | 4202 (16.94) | 11 386 (22.73) |
| 70–79 | 10 079 (39.88) | 9150 (36.88) | 19 229 (38.39) |
| ≥80 | 3060 (12.11) | 9123 (36.77) | 12 183 (24.33) |
| Charlson Comorbidity Index | |||
| 0 | 5924 (23.44) | 7022 (28.30) | 12 946 (25.85) |
| 1 | 8270 (32.72) | 7549 (30.43) | 15 819 (31.58) |
| 2 | 5765 (22.81) | 4824 (19.44) | 10 589 (21.14) |
| ≥3 | 5314 (21.03) | 5416 (21.83) | 10 730 (21.42) |
| Ischaemic aetiology, n (%) | 16 971 (67.15) | 13 901 (56.03) | 30 872 (61.64) |
| History, n (%) | |||
| Hypertension | 14 565 (57.63) | 14 599 (58.84) | 29 164 (58.23) |
| Diabetes | 6905 (27.32) | 6056 (24.41) | 12 961 (25.88) |
| Chronic kidney disease | 3127 (12.37) | 3924 (15.82) | 7051 (14.08) |
| Myocardial infarction | 4092 (16.19) | 2466 (9.94) | 6558 (13.09) |
| CABG | 1354 (5.36) | 834 (3.36) | 2188 (4.37) |
| . | CRT-D . | CRT-P . | All . |
|---|---|---|---|
| N (50 084) | 25 273 | 24 811 | 50 084 |
| Sex (male) | 20 423 (80.81) | 17 088 (68.87) | 37 511 (74.90) |
| Age (years) | 68.1 ± 11.1 | 74.3 ± 11.3 | 71.2 ± 11.6 |
| <60 | 4950 (19.59) | 2336 (9.42) | 7286 (14.55) |
| 60–69 | 7184 (28.43) | 4202 (16.94) | 11 386 (22.73) |
| 70–79 | 10 079 (39.88) | 9150 (36.88) | 19 229 (38.39) |
| ≥80 | 3060 (12.11) | 9123 (36.77) | 12 183 (24.33) |
| Charlson Comorbidity Index | |||
| 0 | 5924 (23.44) | 7022 (28.30) | 12 946 (25.85) |
| 1 | 8270 (32.72) | 7549 (30.43) | 15 819 (31.58) |
| 2 | 5765 (22.81) | 4824 (19.44) | 10 589 (21.14) |
| ≥3 | 5314 (21.03) | 5416 (21.83) | 10 730 (21.42) |
| Ischaemic aetiology, n (%) | 16 971 (67.15) | 13 901 (56.03) | 30 872 (61.64) |
| History, n (%) | |||
| Hypertension | 14 565 (57.63) | 14 599 (58.84) | 29 164 (58.23) |
| Diabetes | 6905 (27.32) | 6056 (24.41) | 12 961 (25.88) |
| Chronic kidney disease | 3127 (12.37) | 3924 (15.82) | 7051 (14.08) |
| Myocardial infarction | 4092 (16.19) | 2466 (9.94) | 6558 (13.09) |
| CABG | 1354 (5.36) | 834 (3.36) | 2188 (4.37) |
All comparisons between CRT-D and CRT-P were significant (P < 0.001).
CABG, coronary artery bypass grafting; CRT, cardiac resynchronization therapy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
